Tasigna Clinical Trials Tasigna RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients With Chronic Myeloid Leukemia
Conditions:   Chronic Myeloid Leukemia, Chronic Phase;   Withdrawal;Drug Interventions:   Drug: Imatinib withdrawal;   Drug: Dasatinib;   Drug: Nilotinib Sponsor:   Masaryk University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials